Urogastrone Reduces Gut Atroprhy during Parenteral Alimentation

L. E. Bragg, T. C. Hollingsed, Jon S Thompson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Urogastrone (UG) exerts trophic effects on the intestine and may play a role in maintaining normal intestinal structure and function. Since administration of nutrients parenterally results in intestinal hypoplasia and hypofunction, the aim of this study was to determine the effects of UG on intestinal structure and function in parenterally fed rats. Central venous catheters were placed into 28 Sprague-Dawley rats. Group I (n = 10) received TPN alone. Group II (n = 8) received TPN and 15 μg/day of UG and group III (n = 10) received rat chow ad libitum. The animals that received urogastrone had significantly greater (p < 0.05) intestinal weight (25.6 ± 2.5 mg/cm us 22.6 ± 3.0 mg/cm), mucosal weight (8.4 + 1.4 mg/cm us 6.2 ± 0.9 mg/cm), mucosal protein content (6.2 ±1.7 mg/ cm us 2.7 ± 0.6 mg/cm), villous height (427 ± 27 μm us 293 ± 75 μm), crypt cell production rate (14.5 ± 1.4 metaphases/hr us 12.3 ± 0.7 metaphases/hr) and sucrase specific activity (6.5 ± 2.6 us 3.7 ± 2.0) than animals receiving only TPN. However, these parameters remained less than in chow-fed animals. Thus, simultaneous infusion of UG prevents, in part, intestinal hypofunction and hypoplasia which occurs during TPN. This may be due to maintenance of mucosal proliferative activity and brush border enzyme activity. (Journal of Parenteral and Enteral Nutrition 14:283-286, 1990).

Original languageEnglish (US)
Pages (from-to)283-286
Number of pages4
JournalJournal of Parenteral and Enteral Nutrition
Volume14
Issue number3
DOIs
StatePublished - Jan 1 1990

Fingerprint

Epidermal Growth Factor
Metaphase
Sucrase
Weights and Measures
Central Venous Catheters
Parenteral Nutrition
Enteral Nutrition
Microvilli
Intestines
Sprague Dawley Rats
Maintenance
Food
Enzymes
Proteins

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Urogastrone Reduces Gut Atroprhy during Parenteral Alimentation. / Bragg, L. E.; Hollingsed, T. C.; Thompson, Jon S.

In: Journal of Parenteral and Enteral Nutrition, Vol. 14, No. 3, 01.01.1990, p. 283-286.

Research output: Contribution to journalArticle

@article{4e04d494fe35467cb50bf2625239e334,
title = "Urogastrone Reduces Gut Atroprhy during Parenteral Alimentation",
abstract = "Urogastrone (UG) exerts trophic effects on the intestine and may play a role in maintaining normal intestinal structure and function. Since administration of nutrients parenterally results in intestinal hypoplasia and hypofunction, the aim of this study was to determine the effects of UG on intestinal structure and function in parenterally fed rats. Central venous catheters were placed into 28 Sprague-Dawley rats. Group I (n = 10) received TPN alone. Group II (n = 8) received TPN and 15 μg/day of UG and group III (n = 10) received rat chow ad libitum. The animals that received urogastrone had significantly greater (p < 0.05) intestinal weight (25.6 ± 2.5 mg/cm us 22.6 ± 3.0 mg/cm), mucosal weight (8.4 + 1.4 mg/cm us 6.2 ± 0.9 mg/cm), mucosal protein content (6.2 ±1.7 mg/ cm us 2.7 ± 0.6 mg/cm), villous height (427 ± 27 μm us 293 ± 75 μm), crypt cell production rate (14.5 ± 1.4 metaphases/hr us 12.3 ± 0.7 metaphases/hr) and sucrase specific activity (6.5 ± 2.6 us 3.7 ± 2.0) than animals receiving only TPN. However, these parameters remained less than in chow-fed animals. Thus, simultaneous infusion of UG prevents, in part, intestinal hypofunction and hypoplasia which occurs during TPN. This may be due to maintenance of mucosal proliferative activity and brush border enzyme activity. (Journal of Parenteral and Enteral Nutrition 14:283-286, 1990).",
author = "Bragg, {L. E.} and Hollingsed, {T. C.} and Thompson, {Jon S}",
year = "1990",
month = "1",
day = "1",
doi = "10.1177/0148607190014003283",
language = "English (US)",
volume = "14",
pages = "283--286",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Urogastrone Reduces Gut Atroprhy during Parenteral Alimentation

AU - Bragg, L. E.

AU - Hollingsed, T. C.

AU - Thompson, Jon S

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Urogastrone (UG) exerts trophic effects on the intestine and may play a role in maintaining normal intestinal structure and function. Since administration of nutrients parenterally results in intestinal hypoplasia and hypofunction, the aim of this study was to determine the effects of UG on intestinal structure and function in parenterally fed rats. Central venous catheters were placed into 28 Sprague-Dawley rats. Group I (n = 10) received TPN alone. Group II (n = 8) received TPN and 15 μg/day of UG and group III (n = 10) received rat chow ad libitum. The animals that received urogastrone had significantly greater (p < 0.05) intestinal weight (25.6 ± 2.5 mg/cm us 22.6 ± 3.0 mg/cm), mucosal weight (8.4 + 1.4 mg/cm us 6.2 ± 0.9 mg/cm), mucosal protein content (6.2 ±1.7 mg/ cm us 2.7 ± 0.6 mg/cm), villous height (427 ± 27 μm us 293 ± 75 μm), crypt cell production rate (14.5 ± 1.4 metaphases/hr us 12.3 ± 0.7 metaphases/hr) and sucrase specific activity (6.5 ± 2.6 us 3.7 ± 2.0) than animals receiving only TPN. However, these parameters remained less than in chow-fed animals. Thus, simultaneous infusion of UG prevents, in part, intestinal hypofunction and hypoplasia which occurs during TPN. This may be due to maintenance of mucosal proliferative activity and brush border enzyme activity. (Journal of Parenteral and Enteral Nutrition 14:283-286, 1990).

AB - Urogastrone (UG) exerts trophic effects on the intestine and may play a role in maintaining normal intestinal structure and function. Since administration of nutrients parenterally results in intestinal hypoplasia and hypofunction, the aim of this study was to determine the effects of UG on intestinal structure and function in parenterally fed rats. Central venous catheters were placed into 28 Sprague-Dawley rats. Group I (n = 10) received TPN alone. Group II (n = 8) received TPN and 15 μg/day of UG and group III (n = 10) received rat chow ad libitum. The animals that received urogastrone had significantly greater (p < 0.05) intestinal weight (25.6 ± 2.5 mg/cm us 22.6 ± 3.0 mg/cm), mucosal weight (8.4 + 1.4 mg/cm us 6.2 ± 0.9 mg/cm), mucosal protein content (6.2 ±1.7 mg/ cm us 2.7 ± 0.6 mg/cm), villous height (427 ± 27 μm us 293 ± 75 μm), crypt cell production rate (14.5 ± 1.4 metaphases/hr us 12.3 ± 0.7 metaphases/hr) and sucrase specific activity (6.5 ± 2.6 us 3.7 ± 2.0) than animals receiving only TPN. However, these parameters remained less than in chow-fed animals. Thus, simultaneous infusion of UG prevents, in part, intestinal hypofunction and hypoplasia which occurs during TPN. This may be due to maintenance of mucosal proliferative activity and brush border enzyme activity. (Journal of Parenteral and Enteral Nutrition 14:283-286, 1990).

UR - http://www.scopus.com/inward/record.url?scp=0025285647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025285647&partnerID=8YFLogxK

U2 - 10.1177/0148607190014003283

DO - 10.1177/0148607190014003283

M3 - Article

VL - 14

SP - 283

EP - 286

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 3

ER -